The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23273992.
- Also identified by DOI 10.1016/j.cell.2012.12.015 and PMC identifier 3556173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Enhancers play a central role in precisely regulating the expression of developmentally regulated genes. However, the machineries required for enhancer-promoter communication have remained largely unknown. We have found that Ell3, a member of the Ell (eleven-nineteen lysine-rich leukemia gene) family of RNA Pol II elongation factors, occupies enhancers in embryonic stem cells. Ell3's association with enhancers is required for setting up proper Pol II occupancy at the promoter-proximal regions of developmentally regulated genes and for the recruitment of the super elongation complex (SEC) to these loci following differentiation signals. Furthermore, Ell3 binding to inactive or poised enhancers is essential for stem cell specification. We have also detected the presence of Pol II and Ell3 in germ cell nuclei. These findings raise the possibility that transcription factors could prime gene expression by marking enhancers in ES cells or even as early as in the germ cell state.
Medical subject headings
- Embryonic Stem Cells
- Enhancer Elements, Genetic
- Transcriptional Activation
- Transcriptional Elongation Factors